ArticleFrontiers in immunology2025

A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer.

Yoshihiko Tasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.